Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

Nearly 1 in 9 adults are living with diabetes, according to new research by the International Diabetes Federation.

Clinical approaches to non-Hodgkin lymphoma in younger and older patient groups generally do not differ, according to Andrew Evens, DO, but he emphasized the need for deeper clinical insights into ...

Lynae Darbes, PhD, discussed the findings of her study, which found that home-based visits helped to encourage the uptake of HIV testing.

The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear ...

The Senate has confirmed Mehmet Oz, MD, to lead CMS, an agency that oversees the health insurance for millions of Americans ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...